New 3D view reveals how T cells target cancer

Visualizing the immune system's precision

For families navigating the complexities of a cancer diagnosis, the body's internal defense mechanisms can often feel like a black box. A study published in Cell Reports on April 28, 2026 has now provided a remarkable window into this hidden world. Scientists at the University of Geneva (UNIGE) and the Lausanne University Hospital (CHUV) have captured the first three-dimensional view of killer T cells - the immune system's specialized cytotoxic lymphocytes - as they identify and dismantle cancerous cells.

To achieve this, the team employed an advanced technique called cryo-expansion microscopy (cryo-ExM), which instantaneously freezes cells in a near-native state before physically expanding them with an absorbent hydrogel, enabling nanometer-scale imaging while preserving delicate biological structures that would otherwise be distorted or lost. This research does more than capture a moment in time - it reveals the intricate molecular architecture of the immune response, offering a new foundation for more refined and less toxic therapies for patients.

At the heart of this discovery is the immune synapse - the tightly controlled contact zone formed when a T cell latches onto a target. To the naked eye, this might look like a simple collision, but at the molecular level, it is a highly coordinated interface. The new 3D imaging reveals that at this contact point, the T cell's membrane forms a dome-shaped structure, whose architecture appears linked to adhesion interactions and the cell's internal organization. By understanding this structure, researchers can better appreciate how our bodies distinguish between a dangerous mutation and a healthy neighbor, ensuring that the immune cell's lethal capacity is deployed only when absolutely necessary.

What is cryo-expansion microscopy (cryo-ExM)?

Understanding the technique behind this breakthrough helps explain why these findings carry such scientific weight. Cryo-expansion microscopy (cryo-ExM) is a next-generation imaging method that combines two powerful approaches: cryogenic preservation and expansion microscopy.

In conventional cryo-electron microscopy, samples are flash-frozen to preserve their structure - but imaging is typically limited to extremely small fields of view. Expansion microscopy physically inflates biological specimens using a superabsorbent hydrogel, making nanoscale structures visible under standard fluorescence microscopes. Cryo-ExM merges both techniques, offering researchers the ability to:

• Freeze cells instantaneously in a near-native state, minimizing structural distortion
• Physically expand the sample to expose molecular-level detail across a wider field
• Image at nanometer resolution - a scale previously accessible only through electron microscopy

This combination is what enabled the UNIGE and CHUV team to image cytotoxic T cells with unprecedented clarity - not only in isolated laboratory cultures, but directly within living human tumor tissue.

The mechanics of selective destruction

Once a killer T cell recognizes a cancer-specific protein on the surface of a target cell, it binds tightly to form the immune synapse. Through this specialized interface, the T cell rearranges its internal skeleton - the cytoskeleton - to direct toxic granules toward the contact zone with remarkable precision.

These granules contain two essential weapons:

• Perforin - a protein that punches pores directly into the cancer cell's outer membrane
• Granzymes (including granzyme B) - enzymes that enter through those pores to trigger programmed cell death, known as apoptosis

What makes this 3D view particularly significant is the unprecedented clarity with which the researchers imaged the cytotoxic granules themselves. The study reveals that these structures are not uniform: they vary in their internal organization, sometimes containing one molecular core and sometimes multiple cores where the active molecules are concentrated. The dome-shaped membrane at the synapse creates a confined delivery space that concentrates the toxic payload directly at the target, minimizing collateral damage to neighboring healthy cells that may be just microns away.

This level of structural detail was previously invisible to science - and it fundamentally changes how researchers can model and replicate the natural killing process.

Transforming the future of immunotherapy

One of the most clinically significant aspects of this study is the team's extension of cryo-ExM beyond isolated laboratory cells and directly into human tumor tissue samples. The researchers were able to observe tumor-infiltrating T lymphocytes and examine their cytotoxic machinery at the nanometer scale in a genuine clinical context - a step that bridges the critical gap between controlled experimental conditions and the full biological complexity found in living patients.

For oncologists and researchers working on the front lines, these 3D maps are more than scientifically striking images - they are structural blueprints. Current immunotherapies, such as CAR-T cell therapy, involve engineering a patient's own T cells to better recognize their specific cancer. While effective - particularly in blood cancers such as leukemia and lymphoma - these treatments can sometimes be unpredictable, and their side effects difficult to anticipate.

By revealing exactly how a natural, highly efficient T cell behaves in three dimensions - including within real tumor tissue - bioengineers now have a clearer reference framework for replicating those molecular patterns in next-generation cell therapies. The structural data from this study could accelerate development across several fronts:

• Next-generation CAR-T therapies engineered with more precise immune synapse mechanics
• Checkpoint inhibitor combinations that better support natural T cell function
• Bispecific antibodies designed to bridge T cells and tumor targets more efficiently

What this discovery means for cancer patients

It is easy to get lost in the technical language of proteins and membranes. But the significance here is deeply human. Each molecular interaction mapped in this study represents a potential decrease in side effects for a real patient - a person who may one day benefit from a treatment designed around this newfound understanding.

When we understand exactly how a T cell delivers its lethal payload while protecting a neighboring healthy cell just microns away, we move measurably closer to therapies that allow patients to undergo treatment without the debilitating exhaustion and systemic illness often associated with traditional chemotherapy. The precision mapped in this research is essentially nature's own blueprint for targeted therapy - and scientists are now reading it at full resolution for the first time.

The integration of this high-resolution 3D data into clinical research is expected to accelerate rapidly. Researchers now hold a reference framework for studying immune responses directly in their clinical context - helping the scientific community better understand not only what drives successful immune attacks against cancer, but critically, what limits them and how those limits might be overcome.

A human-centered approach to biotech

This study is a reminder that even in the face of a disease as complex as cancer, the human body possesses an elegant and sophisticated capacity for defense that we are only just beginning to fully map. The researchers at UNIGE and CHUV have not only advanced the science of immuno-oncology - they have given patients, clinicians, and bioengineers a shared language rooted in real, three-dimensional biology.

As this field continues to evolve at pace, breakthroughs like this serve as essential milestones. They transform abstract cellular processes into visible, understandable structures - and in doing so, bring us measurably closer to a future where cancer treatment is not just effective, but genuinely, precisely humane.